nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC16A1—Methotrexate—multiple sclerosis	0.18	0.642	CbGbCtD
Niacin—CYP2D6—Fingolimod—multiple sclerosis	0.0806	0.288	CbGbCtD
Niacin—CYP2D6—Dexamethasone—multiple sclerosis	0.0196	0.0701	CbGbCtD
Niacin—QPRT—nervous system—multiple sclerosis	0.00842	0.0764	CbGeAlD
Niacin—QPRT—central nervous system—multiple sclerosis	0.00811	0.0735	CbGeAlD
Niacin—SLC16A3—Azacitidine—Cladribine—multiple sclerosis	0.00761	1	CbGdCrCtD
Niacin—QPRT—brain—multiple sclerosis	0.00644	0.0584	CbGeAlD
Niacin—NNMT—medulla oblongata—multiple sclerosis	0.00528	0.0479	CbGeAlD
Niacin—SLC16A3—brainstem—multiple sclerosis	0.00518	0.0469	CbGeAlD
Niacin—SLC16A3—retina—multiple sclerosis	0.00499	0.0453	CbGeAlD
Niacin—NNMT—midbrain—multiple sclerosis	0.00483	0.0438	CbGeAlD
Niacin—NNMT—spinal cord—multiple sclerosis	0.00471	0.0427	CbGeAlD
Niacin—NNMT—nervous system—multiple sclerosis	0.00397	0.036	CbGeAlD
Niacin—NNMT—central nervous system—multiple sclerosis	0.00382	0.0346	CbGeAlD
Niacin—NNMT—cerebellum—multiple sclerosis	0.00374	0.0339	CbGeAlD
Niacin—SLC16A3—medulla oblongata—multiple sclerosis	0.00361	0.0327	CbGeAlD
Niacin—NNMT—brain—multiple sclerosis	0.00303	0.0275	CbGeAlD
Niacin—SLC16A1—retina—multiple sclerosis	0.00303	0.0275	CbGeAlD
Niacin—SLC16A3—nervous system—multiple sclerosis	0.00271	0.0246	CbGeAlD
Niacin—SLC16A3—central nervous system—multiple sclerosis	0.00261	0.0237	CbGeAlD
Niacin—SLC16A3—cerebellum—multiple sclerosis	0.00255	0.0231	CbGeAlD
Niacin—SLC16A1—medulla oblongata—multiple sclerosis	0.00219	0.0199	CbGeAlD
Niacin—SLC16A3—brain—multiple sclerosis	0.00207	0.0188	CbGeAlD
Niacin—SLC16A1—midbrain—multiple sclerosis	0.002	0.0182	CbGeAlD
Niacin—SLC16A1—spinal cord—multiple sclerosis	0.00196	0.0177	CbGeAlD
Niacin—SLCO2B1—medulla oblongata—multiple sclerosis	0.00189	0.0171	CbGeAlD
Niacin—SLC22A5—retina—multiple sclerosis	0.00173	0.0157	CbGeAlD
Niacin—SLCO2B1—spinal cord—multiple sclerosis	0.00168	0.0152	CbGeAlD
Niacin—SLC16A1—nervous system—multiple sclerosis	0.00165	0.0149	CbGeAlD
Niacin—SLC16A1—central nervous system—multiple sclerosis	0.00159	0.0144	CbGeAlD
Niacin—SLC16A1—cerebellum—multiple sclerosis	0.00155	0.0141	CbGeAlD
Niacin—SLCO2B1—nervous system—multiple sclerosis	0.00142	0.0128	CbGeAlD
Niacin—SLCO2B1—central nervous system—multiple sclerosis	0.00136	0.0124	CbGeAlD
Niacin—SLCO2B1—cerebellum—multiple sclerosis	0.00133	0.0121	CbGeAlD
Niacin—SLC16A1—brain—multiple sclerosis	0.00126	0.0114	CbGeAlD
Niacin—SLC22A5—medulla oblongata—multiple sclerosis	0.00125	0.0114	CbGeAlD
Niacin—CYP2D6—brainstem—multiple sclerosis	0.00116	0.0105	CbGeAlD
Niacin—SLC22A5—midbrain—multiple sclerosis	0.00115	0.0104	CbGeAlD
Niacin—SLC22A5—spinal cord—multiple sclerosis	0.00112	0.0101	CbGeAlD
Niacin—SLCO2B1—brain—multiple sclerosis	0.00108	0.00982	CbGeAlD
Niacin—SLC22A5—cerebellum—multiple sclerosis	0.000886	0.00803	CbGeAlD
Niacin—SLC22A5—brain—multiple sclerosis	0.000719	0.00652	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—CXCL10—multiple sclerosis	0.000667	0.00243	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—GPR65—multiple sclerosis	0.000663	0.00242	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000644	0.00235	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—LINGO1—multiple sclerosis	0.000641	0.00234	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CCR1—multiple sclerosis	0.000639	0.00233	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CXCL13—multiple sclerosis	0.000639	0.00233	CbGpPWpGaD
Niacin—NNMT—Metabolism—GPC5—multiple sclerosis	0.000634	0.00231	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—POMC—multiple sclerosis	0.000633	0.00231	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CXCL10—multiple sclerosis	0.000633	0.00231	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000626	0.00228	CbGpPWpGaD
Niacin—CYP2D6—nervous system—multiple sclerosis	0.000607	0.00551	CbGeAlD
Niacin—HCAR3—Signaling by GPCR—CCR1—multiple sclerosis	0.000606	0.00221	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CXCL13—multiple sclerosis	0.000606	0.00221	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—TGFB1—multiple sclerosis	0.000599	0.00219	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000597	0.00218	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MERTK—multiple sclerosis	0.000595	0.00217	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CD58—multiple sclerosis	0.000595	0.00217	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SELPLG—multiple sclerosis	0.000595	0.00217	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000589	0.00215	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TAGAP—multiple sclerosis	0.000586	0.00214	CbGpPWpGaD
Niacin—CYP2D6—central nervous system—multiple sclerosis	0.000585	0.0053	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—CCL5—multiple sclerosis	0.000574	0.0021	CbGpPWpGaD
Niacin—CYP2D6—cerebellum—multiple sclerosis	0.000572	0.00518	CbGeAlD
Niacin—QPRT—Metabolism—RRM1—multiple sclerosis	0.000565	0.00206	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000561	0.00205	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000561	0.00205	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TAGAP—multiple sclerosis	0.000556	0.00203	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CCL5—multiple sclerosis	0.000544	0.00199	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000538	0.00196	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000531	0.00194	CbGpPWpGaD
Niacin—QPRT—Disease—RPL5—multiple sclerosis	0.000529	0.00193	CbGpPWpGaD
Niacin—NNMT—Metabolism—RRM1—multiple sclerosis	0.000525	0.00192	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00052	0.0019	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CCR5—multiple sclerosis	0.000517	0.00189	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—S1PR1—multiple sclerosis	0.000512	0.00187	CbGpPWpGaD
Niacin—QPRT—Disease—SLC11A1—multiple sclerosis	0.000507	0.00185	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000503	0.00184	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GPC5—multiple sclerosis	0.000498	0.00182	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000493	0.0018	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000492	0.0018	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CCR5—multiple sclerosis	0.000491	0.00179	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—S1PR1—multiple sclerosis	0.000486	0.00177	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000483	0.00176	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SRM—multiple sclerosis	0.000481	0.00175	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—SELE—multiple sclerosis	0.00048	0.00175	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000473	0.00172	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GPC5—multiple sclerosis	0.000473	0.00172	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000466	0.0017	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000466	0.0017	CbGpPWpGaD
Niacin—CYP2D6—brain—multiple sclerosis	0.000464	0.00421	CbGeAlD
Niacin—HCAR3—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000458	0.00167	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CCL3—multiple sclerosis	0.000456	0.00166	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000454	0.00166	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000442	0.00161	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000439	0.0016	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000438	0.0016	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RGS1—multiple sclerosis	0.000436	0.00159	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CCL3—multiple sclerosis	0.000432	0.00158	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CCR2—multiple sclerosis	0.00043	0.00157	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000424	0.00155	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00042	0.00153	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000419	0.00153	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PTGER4—multiple sclerosis	0.000416	0.00152	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GPR65—multiple sclerosis	0.000413	0.00151	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RGS1—multiple sclerosis	0.000413	0.00151	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CCR2—multiple sclerosis	0.000412	0.0015	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000412	0.0015	CbGpPWpGaD
Niacin—QPRT—Disease—CD28—multiple sclerosis	0.000405	0.00148	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—POMC—multiple sclerosis	0.000404	0.00148	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000402	0.00147	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CNR1—multiple sclerosis	0.000397	0.00145	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CCL2—multiple sclerosis	0.000396	0.00144	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GPR65—multiple sclerosis	0.000392	0.00143	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CCR2—multiple sclerosis	0.000391	0.00143	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—POMC—multiple sclerosis	0.000383	0.0014	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CNR1—multiple sclerosis	0.00038	0.00139	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCR1—multiple sclerosis	0.000378	0.00138	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL13—multiple sclerosis	0.000378	0.00138	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000377	0.00138	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000376	0.00137	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CCL2—multiple sclerosis	0.000375	0.00137	CbGpPWpGaD
Niacin—Angioedema—Triamcinolone—multiple sclerosis	0.000372	0.00114	CcSEcCtD
Niacin—Haemoglobin—Prednisone—multiple sclerosis	0.000372	0.00113	CcSEcCtD
Niacin—Angioedema—Methylprednisolone—multiple sclerosis	0.000372	0.00113	CcSEcCtD
Niacin—Haemorrhage—Prednisone—multiple sclerosis	0.00037	0.00113	CcSEcCtD
Niacin—Erythema—Dexamethasone—multiple sclerosis	0.00037	0.00113	CcSEcCtD
Niacin—Erythema—Betamethasone—multiple sclerosis	0.00037	0.00113	CcSEcCtD
Niacin—SLC16A1—Hemostasis—PLEK—multiple sclerosis	0.000368	0.00134	CbGpPWpGaD
Niacin—Vertigo—Triamcinolone—multiple sclerosis	0.000366	0.00112	CcSEcCtD
Niacin—Syncope—Triamcinolone—multiple sclerosis	0.000366	0.00111	CcSEcCtD
Niacin—Vertigo—Methylprednisolone—multiple sclerosis	0.000365	0.00111	CcSEcCtD
Niacin—Syncope—Methylprednisolone—multiple sclerosis	0.000365	0.00111	CcSEcCtD
Niacin—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000362	0.0011	CcSEcCtD
Niacin—Oedema—Prednisolone—multiple sclerosis	0.000362	0.0011	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000361	0.00132	CbGpPWpGaD
Niacin—Dizziness—Azathioprine—multiple sclerosis	0.000361	0.0011	CcSEcCtD
Niacin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000361	0.0011	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CNR1—multiple sclerosis	0.000361	0.00132	CbGpPWpGaD
Niacin—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000358	0.00109	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000358	0.00131	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL13—multiple sclerosis	0.000358	0.00131	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCR1—multiple sclerosis	0.000358	0.00131	CbGpPWpGaD
Niacin—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000357	0.00109	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000357	0.0013	CbGpPWpGaD
Niacin—Shock—Prednisolone—multiple sclerosis	0.000356	0.00109	CcSEcCtD
Niacin—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000356	0.00109	CcSEcCtD
Niacin—Cough—Triamcinolone—multiple sclerosis	0.000356	0.00108	CcSEcCtD
Niacin—Tachycardia—Prednisolone—multiple sclerosis	0.000353	0.00108	CcSEcCtD
Niacin—Urticaria—Mitoxantrone—multiple sclerosis	0.00035	0.00107	CcSEcCtD
Niacin—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00035	0.00107	CcSEcCtD
Niacin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000349	0.00106	CcSEcCtD
Niacin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000349	0.00106	CcSEcCtD
Niacin—Myalgia—Triamcinolone—multiple sclerosis	0.000347	0.00106	CcSEcCtD
Niacin—Vomiting—Azathioprine—multiple sclerosis	0.000347	0.00106	CcSEcCtD
Niacin—SLC16A3—Hemostasis—ITGA4—multiple sclerosis	0.000347	0.00127	CbGpPWpGaD
Niacin—Myalgia—Methylprednisolone—multiple sclerosis	0.000346	0.00106	CcSEcCtD
Niacin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000346	0.00106	CcSEcCtD
Niacin—Eye disorder—Prednisone—multiple sclerosis	0.000346	0.00105	CcSEcCtD
Niacin—SLC16A3—Hemostasis—IFNB1—multiple sclerosis	0.000344	0.00126	CbGpPWpGaD
Niacin—Rash—Azathioprine—multiple sclerosis	0.000344	0.00105	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000344	0.00105	CcSEcCtD
Niacin—Dermatitis—Azathioprine—multiple sclerosis	0.000344	0.00105	CcSEcCtD
Niacin—Flushing—Prednisone—multiple sclerosis	0.000343	0.00105	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000342	0.00125	CbGpPWpGaD
Niacin—Headache—Azathioprine—multiple sclerosis	0.000342	0.00104	CcSEcCtD
Niacin—Dry mouth—Triamcinolone—multiple sclerosis	0.000339	0.00103	CcSEcCtD
Niacin—SLC16A3—Metabolism—CYP24A1—multiple sclerosis	0.000339	0.00124	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP27B1—multiple sclerosis	0.000339	0.00124	CbGpPWpGaD
Niacin—Angioedema—Betamethasone—multiple sclerosis	0.000338	0.00103	CcSEcCtD
Niacin—Angioedema—Dexamethasone—multiple sclerosis	0.000338	0.00103	CcSEcCtD
Niacin—Stomatitis—Methotrexate—multiple sclerosis	0.000336	0.00102	CcSEcCtD
Niacin—Angiopathy—Prednisone—multiple sclerosis	0.000336	0.00102	CcSEcCtD
Niacin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000333	0.00101	CcSEcCtD
Niacin—Oedema—Triamcinolone—multiple sclerosis	0.000333	0.00101	CcSEcCtD
Niacin—Vertigo—Betamethasone—multiple sclerosis	0.000332	0.00101	CcSEcCtD
Niacin—Vertigo—Dexamethasone—multiple sclerosis	0.000332	0.00101	CcSEcCtD
Niacin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000332	0.00101	CcSEcCtD
Niacin—Syncope—Dexamethasone—multiple sclerosis	0.000332	0.00101	CcSEcCtD
Niacin—Syncope—Betamethasone—multiple sclerosis	0.000332	0.00101	CcSEcCtD
Niacin—Arrhythmia—Prednisone—multiple sclerosis	0.000331	0.00101	CcSEcCtD
Niacin—Sweating—Methotrexate—multiple sclerosis	0.00033	0.00101	CcSEcCtD
Niacin—Shock—Triamcinolone—multiple sclerosis	0.000327	0.000998	CcSEcCtD
Niacin—Insomnia—Prednisolone—multiple sclerosis	0.000327	0.000998	CcSEcCtD
Niacin—Alopecia—Prednisone—multiple sclerosis	0.000327	0.000997	CcSEcCtD
Niacin—Shock—Methylprednisolone—multiple sclerosis	0.000327	0.000996	CcSEcCtD
Niacin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000325	0.000991	CcSEcCtD
Niacin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000325	0.000991	CcSEcCtD
Niacin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000325	0.000991	CcSEcCtD
Niacin—Paraesthesia—Prednisolone—multiple sclerosis	0.000325	0.000991	CcSEcCtD
Niacin—Tachycardia—Triamcinolone—multiple sclerosis	0.000325	0.00099	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CXCL10—multiple sclerosis	0.000325	0.00118	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000325	0.00118	CbGpPWpGaD
Niacin—QPRT—Metabolism—BCHE—multiple sclerosis	0.000325	0.00118	CbGpPWpGaD
Niacin—Nausea—Azathioprine—multiple sclerosis	0.000324	0.000988	CcSEcCtD
Niacin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000324	0.000988	CcSEcCtD
Niacin—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000324	0.00118	CbGpPWpGaD
Niacin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000322	0.000983	CcSEcCtD
Niacin—Malnutrition—Prednisone—multiple sclerosis	0.000322	0.000982	CcSEcCtD
Niacin—Erythema—Prednisone—multiple sclerosis	0.000322	0.000982	CcSEcCtD
Niacin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000322	0.000981	CcSEcCtD
Niacin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000321	0.000979	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000318	0.00116	CbGpPWpGaD
Niacin—Asthenia—Mitoxantrone—multiple sclerosis	0.000316	0.000965	CcSEcCtD
Niacin—Myalgia—Dexamethasone—multiple sclerosis	0.000315	0.00096	CcSEcCtD
Niacin—Myalgia—Betamethasone—multiple sclerosis	0.000315	0.00096	CcSEcCtD
Niacin—Haemoglobin—Methotrexate—multiple sclerosis	0.000311	0.000948	CcSEcCtD
Niacin—Hypotension—Methylprednisolone—multiple sclerosis	0.00031	0.000946	CcSEcCtD
Niacin—SLC16A3—Metabolism—GPC5—multiple sclerosis	0.00031	0.00113	CbGpPWpGaD
Niacin—Pain—Prednisolone—multiple sclerosis	0.000309	0.000943	CcSEcCtD
Niacin—Hepatitis—Methotrexate—multiple sclerosis	0.000309	0.000943	CcSEcCtD
Niacin—Haemorrhage—Methotrexate—multiple sclerosis	0.000309	0.000943	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—CCL5—multiple sclerosis	0.000308	0.00112	CbGpPWpGaD
Niacin—Vision blurred—Prednisone—multiple sclerosis	0.000304	0.000926	CcSEcCtD
Niacin—SLC5A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000304	0.00111	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000303	0.000924	CcSEcCtD
Niacin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000302	0.000922	CcSEcCtD
Niacin—Oedema—Dexamethasone—multiple sclerosis	0.000302	0.00092	CcSEcCtD
Niacin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000302	0.00092	CcSEcCtD
Niacin—Oedema—Betamethasone—multiple sclerosis	0.000302	0.00092	CcSEcCtD
Niacin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000302	0.00092	CcSEcCtD
Niacin—NNMT—Metabolism—BCHE—multiple sclerosis	0.000302	0.0011	CbGpPWpGaD
Niacin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000302	0.00092	CcSEcCtD
Niacin—Insomnia—Triamcinolone—multiple sclerosis	0.000301	0.000918	CcSEcCtD
Niacin—Insomnia—Methylprednisolone—multiple sclerosis	0.0003	0.000915	CcSEcCtD
Niacin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000299	0.000911	CcSEcCtD
Niacin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000298	0.000909	CcSEcCtD
Niacin—Visual impairment—Methotrexate—multiple sclerosis	0.000298	0.000909	CcSEcCtD
Niacin—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000298	0.00109	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000298	0.00109	CbGpPWpGaD
Niacin—Shock—Dexamethasone—multiple sclerosis	0.000297	0.000906	CcSEcCtD
Niacin—Shock—Betamethasone—multiple sclerosis	0.000297	0.000906	CcSEcCtD
Niacin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000297	0.000904	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CCL5—multiple sclerosis	0.000295	0.00108	CbGpPWpGaD
Niacin—Tachycardia—Betamethasone—multiple sclerosis	0.000295	0.000898	CcSEcCtD
Niacin—Tachycardia—Dexamethasone—multiple sclerosis	0.000295	0.000898	CcSEcCtD
Niacin—Angioedema—Prednisone—multiple sclerosis	0.000294	0.000897	CcSEcCtD
Niacin—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000294	0.00107	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000294	0.00107	CbGpPWpGaD
Niacin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000293	0.000893	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000292	0.00107	CbGpPWpGaD
Niacin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000292	0.000891	CcSEcCtD
Niacin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000292	0.00089	CcSEcCtD
Niacin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000292	0.00089	CcSEcCtD
Niacin—SLC16A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000292	0.00106	CbGpPWpGaD
Niacin—Vertigo—Prednisone—multiple sclerosis	0.000289	0.000882	CcSEcCtD
Niacin—Eye disorder—Methotrexate—multiple sclerosis	0.000289	0.000881	CcSEcCtD
Niacin—QPRT—Disease—CD86—multiple sclerosis	0.000289	0.00105	CbGpPWpGaD
Niacin—Syncope—Prednisone—multiple sclerosis	0.000289	0.000881	CcSEcCtD
Niacin—Tinnitus—Methotrexate—multiple sclerosis	0.000288	0.000879	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000288	0.00105	CbGpPWpGaD
Niacin—Anorexia—Dexamethasone—multiple sclerosis	0.000288	0.000877	CcSEcCtD
Niacin—Anorexia—Betamethasone—multiple sclerosis	0.000288	0.000877	CcSEcCtD
Niacin—Urticaria—Prednisolone—multiple sclerosis	0.000287	0.000876	CcSEcCtD
Niacin—Pain—Triamcinolone—multiple sclerosis	0.000284	0.000868	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000283	0.00103	CbGpPWpGaD
Niacin—Loss of consciousness—Prednisone—multiple sclerosis	0.000283	0.000863	CcSEcCtD
Niacin—Hypotension—Dexamethasone—multiple sclerosis	0.000282	0.00086	CcSEcCtD
Niacin—Hypotension—Betamethasone—multiple sclerosis	0.000282	0.00086	CcSEcCtD
Niacin—Angiopathy—Methotrexate—multiple sclerosis	0.000281	0.000856	CcSEcCtD
Niacin—Vomiting—Mitoxantrone—multiple sclerosis	0.00028	0.000855	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CCL5—multiple sclerosis	0.000279	0.00102	CbGpPWpGaD
Niacin—Rash—Mitoxantrone—multiple sclerosis	0.000278	0.000848	CcSEcCtD
Niacin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000278	0.000847	CcSEcCtD
Niacin—Chills—Methotrexate—multiple sclerosis	0.000277	0.000846	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—CCR5—multiple sclerosis	0.000277	0.00101	CbGpPWpGaD
Niacin—Headache—Mitoxantrone—multiple sclerosis	0.000276	0.000842	CcSEcCtD
Niacin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000275	0.000839	CcSEcCtD
Niacin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000275	0.000839	CcSEcCtD
Niacin—Arthralgia—Prednisone—multiple sclerosis	0.000274	0.000836	CcSEcCtD
Niacin—Myalgia—Prednisone—multiple sclerosis	0.000274	0.000836	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000274	0.000998	CbGpPWpGaD
Niacin—Alopecia—Methotrexate—multiple sclerosis	0.000273	0.000833	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000273	0.000997	CbGpPWpGaD
Niacin—Insomnia—Dexamethasone—multiple sclerosis	0.000273	0.000833	CcSEcCtD
Niacin—Insomnia—Betamethasone—multiple sclerosis	0.000273	0.000833	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000272	0.00083	CcSEcCtD
Niacin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000271	0.000828	CcSEcCtD
Niacin—Paraesthesia—Betamethasone—multiple sclerosis	0.000271	0.000827	CcSEcCtD
Niacin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000271	0.000827	CcSEcCtD
Niacin—Erythema—Methotrexate—multiple sclerosis	0.000269	0.000821	CcSEcCtD
Niacin—Malnutrition—Methotrexate—multiple sclerosis	0.000269	0.000821	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CCL3—multiple sclerosis	0.000269	0.000982	CbGpPWpGaD
Niacin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000267	0.000813	CcSEcCtD
Niacin—Dyspepsia—Betamethasone—multiple sclerosis	0.000266	0.00081	CcSEcCtD
Niacin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000266	0.00081	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CCR5—multiple sclerosis	0.000266	0.000969	CbGpPWpGaD
Niacin—Urticaria—Triamcinolone—multiple sclerosis	0.000264	0.000806	CcSEcCtD
Niacin—Urticaria—Methylprednisolone—multiple sclerosis	0.000264	0.000804	CcSEcCtD
Niacin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000263	0.000802	CcSEcCtD
Niacin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000263	0.000802	CcSEcCtD
Niacin—Oedema—Prednisone—multiple sclerosis	0.000263	0.000802	CcSEcCtD
Niacin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000262	0.0008	CcSEcCtD
Niacin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000262	0.0008	CcSEcCtD
Niacin—Decreased appetite—Betamethasone—multiple sclerosis	0.000262	0.0008	CcSEcCtD
Niacin—Nausea—Mitoxantrone—multiple sclerosis	0.000262	0.000799	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000262	0.000955	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000261	0.000795	CcSEcCtD
Niacin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000261	0.000795	CcSEcCtD
Niacin—SLC16A1—Metabolism—SRM—multiple sclerosis	0.000259	0.000947	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTGER4—multiple sclerosis	0.000259	0.000946	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SELE—multiple sclerosis	0.000259	0.000945	CbGpPWpGaD
Niacin—Shock—Prednisone—multiple sclerosis	0.000259	0.000789	CcSEcCtD
Niacin—Pain—Betamethasone—multiple sclerosis	0.000258	0.000787	CcSEcCtD
Niacin—Pain—Dexamethasone—multiple sclerosis	0.000258	0.000787	CcSEcCtD
Niacin—SLC16A3—Metabolism—RRM1—multiple sclerosis	0.000257	0.000936	CbGpPWpGaD
Niacin—Tachycardia—Prednisone—multiple sclerosis	0.000257	0.000782	CcSEcCtD
Niacin—QPRT—Disease—CCR5—multiple sclerosis	0.000256	0.000935	CbGpPWpGaD
Niacin—Skin disorder—Prednisone—multiple sclerosis	0.000255	0.000779	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—PGR—multiple sclerosis	0.000255	0.000931	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCL3—multiple sclerosis	0.000255	0.000931	CbGpPWpGaD
Niacin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000254	0.000775	CcSEcCtD
Niacin—Vision blurred—Methotrexate—multiple sclerosis	0.000254	0.000774	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CCR5—multiple sclerosis	0.000252	0.000919	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000252	0.000918	CbGpPWpGaD
Niacin—Anorexia—Prednisone—multiple sclerosis	0.000251	0.000764	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00025	0.000913	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCR3—multiple sclerosis	0.00025	0.000913	CbGpPWpGaD
Niacin—QPRT—Disease—HLA-A—multiple sclerosis	0.00025	0.000911	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL2RA—multiple sclerosis	0.000248	0.000905	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CD28—multiple sclerosis	0.000248	0.000905	CbGpPWpGaD
Niacin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000247	0.000753	CcSEcCtD
Niacin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000247	0.000753	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—PTGER4—multiple sclerosis	0.000246	0.000896	CbGpPWpGaD
Niacin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000245	0.000747	CcSEcCtD
Niacin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000245	0.000746	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CCR2—multiple sclerosis	0.000243	0.000888	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PGR—multiple sclerosis	0.000242	0.000883	CbGpPWpGaD
Niacin—Vertigo—Methotrexate—multiple sclerosis	0.000242	0.000737	CcSEcCtD
Niacin—Leukopenia—Methotrexate—multiple sclerosis	0.000241	0.000735	CcSEcCtD
Niacin—Urticaria—Betamethasone—multiple sclerosis	0.00024	0.000731	CcSEcCtD
Niacin—Urticaria—Dexamethasone—multiple sclerosis	0.00024	0.000731	CcSEcCtD
Niacin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000239	0.00073	CcSEcCtD
Niacin—Dizziness—Prednisolone—multiple sclerosis	0.000239	0.000729	CcSEcCtD
Niacin—Asthenia—Triamcinolone—multiple sclerosis	0.000239	0.000728	CcSEcCtD
Niacin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000239	0.000728	CcSEcCtD
Niacin—Abdominal pain—Betamethasone—multiple sclerosis	0.000239	0.000728	CcSEcCtD
Niacin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000239	0.000728	CcSEcCtD
Niacin—Body temperature increased—Betamethasone—multiple sclerosis	0.000239	0.000728	CcSEcCtD
Niacin—Asthenia—Methylprednisolone—multiple sclerosis	0.000238	0.000726	CcSEcCtD
Niacin—Insomnia—Prednisone—multiple sclerosis	0.000238	0.000725	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CXCR3—multiple sclerosis	0.000237	0.000866	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IL2RA—multiple sclerosis	0.000237	0.000864	CbGpPWpGaD
Niacin—Paraesthesia—Prednisone—multiple sclerosis	0.000236	0.00072	CcSEcCtD
Niacin—Pruritus—Triamcinolone—multiple sclerosis	0.000235	0.000718	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CD28—multiple sclerosis	0.000235	0.000858	CbGpPWpGaD
Niacin—Cough—Methotrexate—multiple sclerosis	0.000235	0.000716	CcSEcCtD
Niacin—Pruritus—Methylprednisolone—multiple sclerosis	0.000235	0.000716	CcSEcCtD
Niacin—QPRT—Disease—APOE—multiple sclerosis	0.000233	0.000851	CbGpPWpGaD
Niacin—Dyspepsia—Prednisone—multiple sclerosis	0.000231	0.000706	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CCR2—multiple sclerosis	0.000231	0.000842	CbGpPWpGaD
Niacin—Myalgia—Methotrexate—multiple sclerosis	0.000229	0.000699	CcSEcCtD
Niacin—Arthralgia—Methotrexate—multiple sclerosis	0.000229	0.000699	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—POMC—multiple sclerosis	0.000229	0.000834	CbGpPWpGaD
Niacin—Decreased appetite—Prednisone—multiple sclerosis	0.000229	0.000697	CcSEcCtD
Niacin—Rash—Prednisolone—multiple sclerosis	0.000228	0.000696	CcSEcCtD
Niacin—Dermatitis—Prednisolone—multiple sclerosis	0.000228	0.000695	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000228	0.000694	CcSEcCtD
Niacin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000227	0.000693	CcSEcCtD
Niacin—Headache—Prednisolone—multiple sclerosis	0.000227	0.000691	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CNR1—multiple sclerosis	0.000225	0.00082	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000222	0.000811	CbGpPWpGaD
Niacin—Dizziness—Triamcinolone—multiple sclerosis	0.00022	0.000671	CcSEcCtD
Niacin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00022	0.00067	CcSEcCtD
Niacin—Dizziness—Methylprednisolone—multiple sclerosis	0.000219	0.000669	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—POMC—multiple sclerosis	0.000217	0.000791	CbGpPWpGaD
Niacin—Asthenia—Dexamethasone—multiple sclerosis	0.000217	0.00066	CcSEcCtD
Niacin—Asthenia—Betamethasone—multiple sclerosis	0.000217	0.00066	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000216	0.000789	CbGpPWpGaD
Niacin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000215	0.000655	CcSEcCtD
Niacin—Nausea—Prednisolone—multiple sclerosis	0.000215	0.000655	CcSEcCtD
Niacin—Pruritus—Dexamethasone—multiple sclerosis	0.000214	0.000651	CcSEcCtD
Niacin—Pruritus—Betamethasone—multiple sclerosis	0.000214	0.000651	CcSEcCtD
Niacin—Skin disorder—Methotrexate—multiple sclerosis	0.000213	0.000651	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CNR1—multiple sclerosis	0.000213	0.000777	CbGpPWpGaD
Niacin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000212	0.000648	CcSEcCtD
Niacin—Vomiting—Triamcinolone—multiple sclerosis	0.000212	0.000645	CcSEcCtD
Niacin—Vomiting—Methylprednisolone—multiple sclerosis	0.000211	0.000644	CcSEcCtD
Niacin—QPRT—Disease—CD80—multiple sclerosis	0.000211	0.000769	CbGpPWpGaD
Niacin—Rash—Triamcinolone—multiple sclerosis	0.00021	0.00064	CcSEcCtD
Niacin—Dermatitis—Triamcinolone—multiple sclerosis	0.00021	0.000639	CcSEcCtD
Niacin—Anorexia—Methotrexate—multiple sclerosis	0.000209	0.000639	CcSEcCtD
Niacin—Rash—Methylprednisolone—multiple sclerosis	0.000209	0.000638	CcSEcCtD
Niacin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000209	0.000638	CcSEcCtD
Niacin—Urticaria—Prednisone—multiple sclerosis	0.000209	0.000637	CcSEcCtD
Niacin—Headache—Triamcinolone—multiple sclerosis	0.000208	0.000636	CcSEcCtD
Niacin—Headache—Methylprednisolone—multiple sclerosis	0.000208	0.000634	CcSEcCtD
Niacin—Abdominal pain—Prednisone—multiple sclerosis	0.000208	0.000634	CcSEcCtD
Niacin—Body temperature increased—Prednisone—multiple sclerosis	0.000208	0.000634	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—POMC—multiple sclerosis	0.000208	0.000757	CbGpPWpGaD
Niacin—Diarrhoea—Betamethasone—multiple sclerosis	0.000207	0.00063	CcSEcCtD
Niacin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000207	0.00063	CcSEcCtD
Niacin—Hypotension—Methotrexate—multiple sclerosis	0.000205	0.000626	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CCL2—multiple sclerosis	0.000203	0.000741	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL10—multiple sclerosis	0.000202	0.000738	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.0002	0.00061	CcSEcCtD
Niacin—Dizziness—Dexamethasone—multiple sclerosis	0.0002	0.000609	CcSEcCtD
Niacin—Dizziness—Betamethasone—multiple sclerosis	0.0002	0.000609	CcSEcCtD
Niacin—Insomnia—Methotrexate—multiple sclerosis	0.000199	0.000606	CcSEcCtD
Niacin—Nausea—Triamcinolone—multiple sclerosis	0.000198	0.000603	CcSEcCtD
Niacin—Paraesthesia—Methotrexate—multiple sclerosis	0.000197	0.000602	CcSEcCtD
Niacin—Nausea—Methylprednisolone—multiple sclerosis	0.000197	0.000601	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—POMC—multiple sclerosis	0.000197	0.000718	CbGpPWpGaD
Niacin—Dyspnoea—Methotrexate—multiple sclerosis	0.000196	0.000597	CcSEcCtD
Niacin—Somnolence—Methotrexate—multiple sclerosis	0.000195	0.000596	CcSEcCtD
Niacin—QPRT—Metabolism—APOE—multiple sclerosis	0.000195	0.000713	CbGpPWpGaD
Niacin—Hypersensitivity—Prednisone—multiple sclerosis	0.000194	0.000591	CcSEcCtD
Niacin—Dyspepsia—Methotrexate—multiple sclerosis	0.000193	0.00059	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CCL2—multiple sclerosis	0.000192	0.000702	CbGpPWpGaD
Niacin—Vomiting—Dexamethasone—multiple sclerosis	0.000192	0.000585	CcSEcCtD
Niacin—Vomiting—Betamethasone—multiple sclerosis	0.000192	0.000585	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CXCL10—multiple sclerosis	0.000192	0.0007	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000191	0.000698	CbGpPWpGaD
Niacin—Decreased appetite—Methotrexate—multiple sclerosis	0.000191	0.000582	CcSEcCtD
Niacin—Rash—Betamethasone—multiple sclerosis	0.00019	0.00058	CcSEcCtD
Niacin—Rash—Dexamethasone—multiple sclerosis	0.00019	0.00058	CcSEcCtD
Niacin—Dermatitis—Dexamethasone—multiple sclerosis	0.00019	0.00058	CcSEcCtD
Niacin—Dermatitis—Betamethasone—multiple sclerosis	0.00019	0.00058	CcSEcCtD
Niacin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00019	0.000578	CcSEcCtD
Niacin—Headache—Betamethasone—multiple sclerosis	0.000189	0.000577	CcSEcCtD
Niacin—Headache—Dexamethasone—multiple sclerosis	0.000189	0.000577	CcSEcCtD
Niacin—Asthenia—Prednisone—multiple sclerosis	0.000189	0.000575	CcSEcCtD
Niacin—Pain—Methotrexate—multiple sclerosis	0.000188	0.000573	CcSEcCtD
Niacin—SLC16A1—Hemostasis—ITGA4—multiple sclerosis	0.000187	0.000683	CbGpPWpGaD
Niacin—Pruritus—Prednisone—multiple sclerosis	0.000186	0.000567	CcSEcCtD
Niacin—SLC16A1—Hemostasis—IFNB1—multiple sclerosis	0.000186	0.000678	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—TYK2—multiple sclerosis	0.000184	0.000673	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP24A1—multiple sclerosis	0.000183	0.000667	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP27B1—multiple sclerosis	0.000183	0.000667	CbGpPWpGaD
Niacin—NNMT—Metabolism—APOE—multiple sclerosis	0.000182	0.000662	CbGpPWpGaD
Niacin—Diarrhoea—Prednisone—multiple sclerosis	0.00018	0.000548	CcSEcCtD
Niacin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00018	0.000548	CcSEcCtD
Niacin—Nausea—Dexamethasone—multiple sclerosis	0.000179	0.000547	CcSEcCtD
Niacin—Nausea—Betamethasone—multiple sclerosis	0.000179	0.000547	CcSEcCtD
Niacin—QPRT—Disease—TYK2—multiple sclerosis	0.000178	0.000649	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000177	0.000647	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CD86—multiple sclerosis	0.000177	0.000645	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—TYK2—multiple sclerosis	0.000175	0.000638	CbGpPWpGaD
Niacin—Urticaria—Methotrexate—multiple sclerosis	0.000175	0.000532	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CCL5—multiple sclerosis	0.000174	0.000635	CbGpPWpGaD
Niacin—Dizziness—Prednisone—multiple sclerosis	0.000174	0.00053	CcSEcCtD
Niacin—Body temperature increased—Methotrexate—multiple sclerosis	0.000174	0.00053	CcSEcCtD
Niacin—Abdominal pain—Methotrexate—multiple sclerosis	0.000174	0.00053	CcSEcCtD
Niacin—SLC16A3—Hemostasis—ALB—multiple sclerosis	0.000171	0.000625	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—IL2—multiple sclerosis	0.000169	0.000617	CbGpPWpGaD
Niacin—QPRT—Metabolism—POMC—multiple sclerosis	0.000168	0.000612	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CD86—multiple sclerosis	0.000168	0.000612	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GPC5—multiple sclerosis	0.000167	0.00061	CbGpPWpGaD
Niacin—Vomiting—Prednisone—multiple sclerosis	0.000167	0.00051	CcSEcCtD
Niacin—Rash—Prednisone—multiple sclerosis	0.000166	0.000505	CcSEcCtD
Niacin—Dermatitis—Prednisone—multiple sclerosis	0.000166	0.000505	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CCL5—multiple sclerosis	0.000165	0.000602	CbGpPWpGaD
Niacin—Headache—Prednisone—multiple sclerosis	0.000165	0.000502	CcSEcCtD
Niacin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000162	0.000494	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—SPP1—multiple sclerosis	0.000161	0.000588	CbGpPWpGaD
Niacin—QPRT—Disease—CD4—multiple sclerosis	0.000161	0.000587	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—IL2—multiple sclerosis	0.00016	0.000584	CbGpPWpGaD
Niacin—Asthenia—Methotrexate—multiple sclerosis	0.000158	0.000481	CcSEcCtD
Niacin—SLC16A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000158	0.000575	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCR5—multiple sclerosis	0.000157	0.000572	CbGpPWpGaD
Niacin—Nausea—Prednisone—multiple sclerosis	0.000156	0.000476	CcSEcCtD
Niacin—NNMT—Metabolism—POMC—multiple sclerosis	0.000156	0.000569	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000156	0.000568	CbGpPWpGaD
Niacin—Pruritus—Methotrexate—multiple sclerosis	0.000155	0.000474	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—IL2RA—multiple sclerosis	0.000155	0.000564	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL2—multiple sclerosis	0.000153	0.00056	CbGpPWpGaD
Niacin—QPRT—Metabolism—ALB—multiple sclerosis	0.000153	0.000558	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SPP1—multiple sclerosis	0.000153	0.000558	CbGpPWpGaD
Niacin—Diarrhoea—Methotrexate—multiple sclerosis	0.00015	0.000458	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CCR5—multiple sclerosis	0.000149	0.000543	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000148	0.000541	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—BCHE—multiple sclerosis	0.000147	0.000538	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2RA—multiple sclerosis	0.000147	0.000535	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL2—multiple sclerosis	0.000145	0.000531	CbGpPWpGaD
Niacin—Dizziness—Methotrexate—multiple sclerosis	0.000145	0.000443	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—APOE—multiple sclerosis	0.000143	0.000521	CbGpPWpGaD
Niacin—NNMT—Metabolism—ALB—multiple sclerosis	0.000142	0.000519	CbGpPWpGaD
Niacin—Vomiting—Methotrexate—multiple sclerosis	0.00014	0.000426	CcSEcCtD
Niacin—SLC16A3—Hemostasis—IL2—multiple sclerosis	0.000139	0.000507	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—RRM1—multiple sclerosis	0.000139	0.000506	CbGpPWpGaD
Niacin—Rash—Methotrexate—multiple sclerosis	0.000139	0.000422	CcSEcCtD
Niacin—Dermatitis—Methotrexate—multiple sclerosis	0.000138	0.000422	CcSEcCtD
Niacin—Headache—Methotrexate—multiple sclerosis	0.000138	0.00042	CcSEcCtD
Niacin—SLC22A5—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000135	0.000494	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APOE—multiple sclerosis	0.000135	0.000494	CbGpPWpGaD
Niacin—Nausea—Methotrexate—multiple sclerosis	0.00013	0.000398	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CD80—multiple sclerosis	0.000129	0.000471	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2RA—multiple sclerosis	0.000128	0.000467	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000126	0.00046	CbGpPWpGaD
Niacin—QPRT—Disease—STAT3—multiple sclerosis	0.000125	0.000455	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—POMC—multiple sclerosis	0.000123	0.000447	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CD80—multiple sclerosis	0.000122	0.000446	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCL2—multiple sclerosis	0.00012	0.000438	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—MAPK1—multiple sclerosis	0.000117	0.000428	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—POMC—multiple sclerosis	0.000116	0.000424	CbGpPWpGaD
Niacin—QPRT—Disease—MYC—multiple sclerosis	0.000116	0.000423	CbGpPWpGaD
Niacin—QPRT—Disease—TGFB1—multiple sclerosis	0.000115	0.000421	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCL2—multiple sclerosis	0.000114	0.000415	CbGpPWpGaD
Niacin—QPRT—Disease—MAPK1—multiple sclerosis	0.000113	0.000413	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—MAPK1—multiple sclerosis	0.000111	0.000406	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TYK2—multiple sclerosis	0.000109	0.000397	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TGFB1—multiple sclerosis	0.000108	0.000395	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—MAPK1—multiple sclerosis	0.000106	0.000388	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TYK2—multiple sclerosis	0.000103	0.000377	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ALB—multiple sclerosis	9.25e-05	0.000337	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—multiple sclerosis	9.06e-05	0.000331	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—multiple sclerosis	9.02e-05	0.000329	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.01e-05	0.000329	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—APOE—multiple sclerosis	8.86e-05	0.000324	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—multiple sclerosis	8.7e-05	0.000318	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—multiple sclerosis	8.59e-05	0.000314	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—multiple sclerosis	8.58e-05	0.000313	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—multiple sclerosis	8.55e-05	0.000312	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—multiple sclerosis	8.13e-05	0.000297	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8e-05	0.000292	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—BCHE—multiple sclerosis	7.96e-05	0.00029	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—multiple sclerosis	7.63e-05	0.000278	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—POMC—multiple sclerosis	7.62e-05	0.000278	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—multiple sclerosis	7.5e-05	0.000274	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—multiple sclerosis	7.23e-05	0.000264	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SRM—multiple sclerosis	7.23e-05	0.000264	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—multiple sclerosis	7.09e-05	0.000259	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—multiple sclerosis	7.07e-05	0.000258	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALB—multiple sclerosis	6.94e-05	0.000253	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK1—multiple sclerosis	6.93e-05	0.000253	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.88e-05	0.000251	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—multiple sclerosis	6.72e-05	0.000245	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—multiple sclerosis	6.7e-05	0.000245	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—POMC—multiple sclerosis	6.7e-05	0.000244	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK1—multiple sclerosis	6.57e-05	0.00024	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—multiple sclerosis	5.85e-05	0.000213	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK1—multiple sclerosis	5.74e-05	0.000209	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—multiple sclerosis	5.33e-05	0.000194	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	5.09e-05	0.000186	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	5.09e-05	0.000186	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—multiple sclerosis	5.05e-05	0.000184	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOE—multiple sclerosis	4.79e-05	0.000175	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.66e-05	0.00017	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—POMC—multiple sclerosis	4.11e-05	0.00015	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.86e-05	0.000141	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—multiple sclerosis	3.75e-05	0.000137	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.22e-05	8.09e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOE—multiple sclerosis	1.33e-05	4.87e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—POMC—multiple sclerosis	1.15e-05	4.18e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—multiple sclerosis	1.04e-05	3.81e-05	CbGpPWpGaD
